1.1 |
Product Identifier |
||||||
Product Name |
Clary Sage Oil |
||||||
Biological Definition |
Salvia Sclarea Oil is a volatile oil obtained from the Clary Sage, Salvia sclarea L., Lamiaceae. |
||||||
INCI Name |
Salvia Sclarea Oil |
||||||
Synonyms & Trade Names |
- |
||||||
CAS-No |
8016-63-5 / 84775-83-7 |
EC No. |
- / 283-911-8 |
EINECS No. |
- / 283-911-8 |
||
1.2 |
Relative identified uses of the substance or mixture and uses advised against |
||||||
|
No additional data available. |
||||||
1.3 |
Details of the supplier of the safety data sheet |
||||||
|
Essential Oils Direct Ltd 13 Parkside Industrial Estate, Royton, Oldham OL2 6DS - Reg No 04199912 |
||||||
1.4 |
Emergency Tel. No. |
+ 44 (0) 161 633 3952 |
|||||
|
|
|
|
|
|
|
|
2.1 |
Classification of the substance or mixture |
||
|
The full text for all hazard statements is displayed in Section 16.
|
||
Classification (EC 1272/2008) |
|||
|
Physical and Chemical Hazards: This mixture does not present a physical hazard.
Human health Asp: Skin irritation, Category 2 (Skin Irrit. 2, H315). Eye irritation, Category 2 (Eye Irrit. 2, H319). Skin sensitisation, Category 1 (Skin Sens. 1, H317).
Environment: This mixture does not present an environmental hazard.
|
||
2.2 |
Label Elements |
||
Label in accordance with (EC) No 1272/2008 |
|||
|
GHS07
|
||
Signal Word |
Warning |
||
Contains |
EC 203-377-1 GERANIOL EC 203-341-5 GERANYL ACETATE EC 227-813-5 D-LIMONENE |
||
Hazard Statements |
|||
|
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. |
||
Precautionary Statements |
|||
|
P280 Wear protective gloves/protective clothing/eye protection/face protection. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. |
||
Supplementary Precautionary Statements |
|||
|
None. |
||
2.3 |
Other Hazards |
||
PBT or vPvB according to Annex XIII |
The substance does not satisfy the PBT or vPvP criteria in accordance with annexe XIII of the REACH regulations EC 1907/2006. |
||
Adverse physio-chemical properties |
No additional data available. |
||
Adverse effects on human health |
No additional data available. |
||
|
|
|
|
3.1 |
Substances |
|
50.0 - 100%Linalyl Acetate CAS-No.: 115-95-7 EC No.: 204-116-4
Classification (EC 1272/2008) GHS07, Wng. Eye Irrit. 2, H319, Skin Irrit. 2, H315
|
|
15.0 – 30.0%Linalool CAS-No.: 78-70-6 EC No.: 201-134-4
Classification (EC 1272/2008) GHS07, Wng. Eye Irrit. 2, H319, Skin Irrit. 2, H315
|
|
< 2.5%Geraniol CAS-No.: 106-24-1 EC No.: 204-377-1
Classification (EC 1272/2008) GHS05, GHS07, Dgr. Skin Irrit. 2, H315, Skin Sens. 1, H317, Eye Dam. 1, H318
|
|
< 2.5%Geranyl Acetate CAS-No.: 105-87-3 EC No.: 203-341-5
Classification (EC 1272/2008) GHS07, Wng. Eye Irrit. 2, H319, Skin Irrit. 2, H315
|
|
< 2.5%Alpha Terpineol CAS-No.: 98-55-5 EC No.: 202-680-6
Classification (EC 1272/2008) GHS07, Wng. Eye Irrit. 2, H319, Skin Irrit. 2, H315
|
|
< 2.5%D-Limonene CAS-No.: 5989-27-5 EC No.: 227-813-5
Classification (EC 1272/2008) GHS08, GHS02, GHS07, GHS09, Dgr. Asp. Tox. 1, H304, Flam. Liq. 3, H226, Skin Irrit. 2, H315, Skin Sens. 1B, H317, Aquatic Acute 1, H400, M Acute = 1. Aquatic Chronic 1, H410, M Chronic = 1
|
4.1 |
Description of first aid measures |
|
Inhalation |
Remove victim immediately from source of exposure. Get medical attention. |
|
Ingestion |
Do not give the patient anything orally. In the event of swallowing, if the quantity is small (no more than one mouthful), rinse the mouth with water and consult a doctor. Seek medical attention immediately, showing the label. |
|
Skin Contact |
Remove contaminated clothing immediately and wash skin with soap and water. Get medical attention if any discomfort continues. |
|
Eye Contact |
Immediately flush with plenty of water for up to 15 minutes. Remove any contact lenses and open eyes wide apart. Get medical attention. Continue to rinse. |
|
4.2 |
Most important symptoms and effects, both acute and delayed |
|
|
No additional data available. |
|
4.3 |
Indication of any immediate medical attention and special treatment needed |
|
|
No additional data available. |
|
|
|
|
5.1 |
Extinguishing Media |
|
Non flammable, therefore extinguish flames as per surrounding area dictates. Extinguishing media: Carbon dioxide (CO2). Powder. Water spray. |
5.2 |
Special hazards arising from the product |
|
A fire will often produce a thick black smoke. Exposure to decomposition products may be hazardous to health. Do not breathe in smoke. In the event of a fire, the following may be formed: carbon monoxide (CO) and carbon dioxide (CO2) |
5.3 |
Advice for firefighters |
|
Special Fire Fighting Procedures - Do not allow spillage into drains or waterways. |
6.1 |
Personal precautions, protective equipment and emergency procedures |
|
Wear protective clothing as described in Section 8 of this safety data sheet. Handle the product using protective gloves resistant to the chemicals exposed. Avoid contact with skin and eyes. Maintain adequate ventilation in the working area after spilling. |
6.2 |
Environmental Precautions |
|
Do not discharge into drains, water courses or onto the ground. |
6.3 |
Methods and material for containment and cleaning up. |
|
Cover with an inert, inorganic, non-combustible absorbent material (e.g. dry-lime, sand, soda ash). Place in covered containers using non-sparking tools and transport outdoors. Ventilate area and wash spill site with detergent after material pickup is complete. Do not use solvents. Dispose of in accordance with current laws and regulations. |
6.4 |
Reference to other sections |
|
Wear protective clothing as described in Section 8 of this safety data sheet. |
7.1 |
Precautions for safe handling |
|
Requirements relating to storage premises apply to all facilities where the substance is handled. Individuals with a history of skin sensitisation should not, under any circumstance, handle this substance. Always wash hands after handling. Avoid contact with skin and eyes. Remove and wash contaminated clothing before re-using. Prevent access by unauthorised personnel. No smoking, eating or drinking in areas where the substance is used. |
7.2 |
Conditions for safe storage, including any incompatibilities |
|
Keep product well sealed, in a dry, ventilated area and protected from light. Keep away from food, drink and animal feeding stuffs. Stock according to local / national regulations and always follow the precautions indicated on labels. Always keep in packaging made of an identical material to the original. |
7.3 |
Specific end use(s) |
|
No additional data available. |
8.1 |
Control parameters |
||
|
Derived no effect level (DNEL) or derived minimum effect level (DMEL): Workers Exposure method: Dermal contact. Potential health effects: Short term systemic effects. DNEL : 5 mg/kg body weight/day
Exposure method: Dermal contact. Potential health effects: Short term local effects. DNEL : 15 mg of substance/cm2
Exposure method: Dermal contact. Potential health effects: Long term systemic effects. DNEL : 2.5 mg/kg body weight/day
Exposure method: Dermal contact. Potential health effects: Long term local effects. DNEL : 15 mg of substance/cm2
Exposure method: Dermal contact. Potential health effects: Short term systemic effects. DNEL : 5 mg/kg body weight/day
Exposure method: Dermal contact. Potential health effects: Short term local effects. DNEL : 15 mg of substance/cm2
Exposure method: Dermal contact. Potential health effects: Long term systemic effects. DNEL : 2.5 mg/kg body weight/day
Exposure method: Dermal contact. Potential health effects: Long term local effects. DNEL : 15 mg of substance/cm2
Exposure method: Inhalation. Potential health effects: Short term systemic effects. DNEL : 16.5 mg of substance/m3
Exposure method: Inhalation. Potential health effects: Long term systemic effects. DNEL : 2.8 mg of substance/m3
Exposure method: Inhalation. Potential health effects: Short term systemic effects. DNEL : 16.5 mg of substance/m3
Exposure method: Inhalation. Potential health effects: Long term systemic effects. DNEL : 2.8 mg of substance/m3
Consumers Exposure method: Ingestion. Potential health effects: Short term systemic effects. DNEL : 1.2 mg/kg body weight/day
Exposure method: Ingestion. Potential health effects: Long term systemic effects. DNEL : 0.2 mg/kg body weight/day
Exposure method: Ingestion. Potential health effects: Short term systemic effects. DNEL : 1.2 mg/kg body weight/day
Exposure method: Ingestion. Potential health effects: Long term systemic effects. DNEL : 0.2 mg/kg body weight/day
Exposure method: Dermal contact. Potential health effects: Short term systemic effects. DNEL : 2.5 mg/kg body weight/day
Exposure method: Dermal contact. Potential health effects: Short term local effects. DNEL : 15 mg of substance/cm2
Exposure method: Dermal contact. Potential health effects: Long term systemic effects. DNEL : 1.25 mg/kg body weight/day
Exposure method: Dermal contact. Potential health effects: Long term local effects. DNEL : 15 mg of substance/cm2
Exposure method: Dermal contact. Potential health effects: Short term systemic effects. DNEL : 2.5 mg/kg body weight/day
Exposure method: Dermal contact. Potential health effects: Short term local effects. DNEL : 15 mg of substance/cm2
Exposure method: Dermal contact. Potential health effects: Long term systemic effects. DNEL : 1.25 mg/kg body weight/day
Exposure method: Dermal contact. Potential health effects: Long term local effects. DNEL : 15 mg of substance/cm2
Exposure method: Inhalation. Potential health effects: Short term systemic effects. DNEL : 4.1 mg of substance/m3
Exposure method: Inhalation. Potential health effects: Long term systemic effects. DNEL : 0.7 mg of substance/m3
Exposure method: Inhalation. Potential health effects: Short term systemic effects. DNEL : 4.1 mg of substance/m3
Exposure method: Inhalation. Potential health effects: Long term systemic effects. DNEL : 0.7 mg of substance/m3
Predicted no effect concentration (PNEC):
Environmental compartment: Soil.PNEC : 0.327 mg/kg Environmental compartment: Soil.PNEC : 0.327 mg/kg Environmental compartment: Fresh water.PNEC : 0.2 mg/l Environmental compartment: Fresh water.PNEC : 0.2 mg/l Environmental compartment: Sea water.PNEC : 0.02 mg/l Environmental compartment: Sea water.PNEC : 0.02 mg/l Environmental compartment: Intermittent waste water.PNEC : 2 mg/l Environmental compartment: Intermittent waste water.PNEC : 2 mg/l Environmental compartment: Fresh water sediment.PNEC : 2.22 mg/kg Environmental compartment: Fresh water sediment.PNEC : 2.22 mg/kg Environmental compartment: Marine sediment.PNEC : 0.222 mg/kg Environmental compartment: Marine sediment.PNEC : 0.222 mg/kg Environmental compartment: Waste water treatment plant.PNEC : 10 mg/l Environmental compartment: Waste water treatment plant.PNEC : 10 mg/l
|
||
8.2 |
Exposure controls |
||
Protective Equipment |
|||
|
|
||
Process Conditions |
Provide eyewash station. |
||
Engineering Measures |
Provide adequate ventilation. |
||
Respiratory Equipment |
Wear suitable respiratory equipment. |
||
Hand Protection |
Wear suitable protective gloves in the event of prolonged or repeated skin contact. Use suitable protective gloves that are resistant to chemical agents in accordance with standard EN374. Gloves must be selected according to the application and duration of use at the workstation. Protective gloves need to be selected according to their suitability for the workstation in question : other chemical products that may be handled, necessary physical protections (cutting, pricking, heat protection), level of dexterity required. Recommended properties:Impervious gloves in accordance with standard EN374 |
||
Eye Protection |
Avoid contact with eyes. Use eye protectors designed to protect against liquid splashes. Before handling, wear safety goggles with protective sides in accordance with standard EN166. In the event of high danger, protect the face with a face shield. Prescription glasses are not considered as protection. Individuals wearing contact lenses should wear prescription glasses during work where they may be exposed to irritant vapours. Provide eyewash stations in facilities where the product is handled constantly. |
||
Other Protection |
Wear appropriate clothing to prevent any possibility of skin contact. |
||
Hygiene Measures |
Good personal hygiene practices are always advisable, especially when working with chemicals / oils. |
||
Personal Protection |
Avoid inhalation and contact with skin and eyes. Use personal protective equipment that is clean and has been properly maintained. Store personal protective equipment in a clean place, away from the work area. |
||
Skin Protection |
Avoid skin contact. Wear suitable protective clothing. Suitable type of protective clothing : In the event of substantial spatter, wear liquid-tight protective clothing against chemical risks (type 3) in accordance with EN14605 to prevent skin contact. In the event of a risk of splashing, wear protective clothing against chemical risks (type 6) in accordance with EN13034 to prevent skin contact. Work clothing worn by personnel shall be laundered regularly. After contact with the product, all parts of the body that have been soiled must be washed. |
||
Environmental Exposure Controls |
Avoid discharging into drainage water. Only eliminate by authorised companies. |
||
|
|
|
|
9.1 |
Information on basic physical and chemical properties |
|
Appearance |
Clear liquid colourless to yellow-brown, often pale yellow. |
|
Colour |
Colourless to yellow-brown, often pale yellow. |
|
Odour |
Characteristic, Ethereal, sweet, herbaceous, amber clinging. |
|
Relative Density |
Approx. 0.910 @ 20°C |
|
Flash Point (°C) |
+81.0 |
|
Refractive Index |
Approx. 1.465 @ 20°C |
|
Melting Point (°C) |
No additional data available. |
|
Boiling Point (°C) |
No additional data available. |
|
Vapour Pressure |
No additional data available. |
|
Solubility in Water @20°C |
Insoluble in water. |
|
Auto-ignition temperature (°C) |
No additional data available. |
|
9.2 |
Other information |
|
|
No additional data available. |
|
|
|
|
10.1 |
Reactivity |
|
|
Stable under the recommended handling and storage conditions. |
|
10.2 |
Chemical stability |
|
|
Stable under the recommended handling and storage conditions. |
|
10.3 |
Possible hazardous reactions |
|
|
No additional data available. |
|
10.4 |
Conditions to Avoid |
|
|
No additional data available. |
|
10.5 |
Incompatible materials |
|
|
No additional data available. |
|
10.6 |
Hazardous Decomposition Products |
|
|
The thermal decomposition may release/form carbon monoxide (CO) and carbon dioxide (CO2). |
|
|
|
|
11.1 |
Information on toxicological effects |
||
|
Acute Toxicity |
ALPHA-TERPINEOL (CAS: 98-55-5)Oral route : LD50 = 4300 mg/kg GERANIOL (CAS: 106-24-1)Oral route : LD50 = 4200 mg/kg LINALOOL (CAS: 78-70-6)Oral route : LD50 = 2790 mg/kg |
|
|
Skin corrosion / irritation |
May cause irreversible damage to the skin; namely inflammation of the skin or the formation of erythema and eschar or oedema following exposure up to four hours. May cause an allergic reaction by skin contact. |
|
|
Serious eye damage / irritation |
May have reversible effects on the eyes, such as eye irritation which is totally reversible by the end of observation at 21 days. |
|
|
Respiratory or skin sensitisation |
May cause irreversible damage to the skin; namely inflammation of the skin or the formation of erythema and eschar or oedema following exposure up to four hours. May cause an allergic reaction by skin contact. |
|
|
Germ Cell Mutagenicity |
No additional data available. |
|
|
Carcinogenicity |
CAS 5989-27-5 : IARC Group 3 : The agent is not classifiable as to its carcinogenicity to humans. |
|
|
Reproductive toxicity |
No additional data available. |
|
|
STOT-single exposure |
No additional data available. |
|
|
STOT-repeated exposure |
No additional data available. |
|
|
Aspiration hazard |
No additional data available. |
|
|
Photo-toxicity |
No additional data available. |
|
|
Other Information |
No additional data available. |
|
|
|
|
|
12.1 |
Toxicity |
|
|
No additional data available. |
|
12.2 |
Persistence & degradability |
|
|
No additional data available. |
|
12.3 |
Bioaccumulation Potential |
|
|
No additional data available.
|
|
12.4 |
Mobility in soil |
|
|
No additional data available. |
|
12.5 |
Results of PBT and vPvB Assessment |
|
|
No additional data available. |
|
12.6 |
Other adverse effects |
|
|
Do not allow product to enter streams, sewers or other waterways. |
|
|
|
|
13.1 |
Waste treatment methods |
|
|
Dispose of in compliance with all local and national regulations. Proper waste management of the mixture and/or its container must be determined in accordance with Directive 2008/98/EC. Do not pour into drains or waterways. Waste: Do not pour into drains or waterways. Waste management is carried out without endangering human health, without harming the environment and, in particular without risk to water, air, soil, plants or animals. Recycle or dispose of waste in compliance with current legislation, preferably via a certified collector or company. Do not contaminate the ground or water with waste, do not dispose of waste into the environment. Soiled packaging: Empty container completely. Keep label(s) on container. Give to a certified disposal contractor.
|
|
|
|
|
14.1 |
UN number |
||
|
UN No. Road |
Not bound by transport regulations. |
|
|
UN No. SEA |
Not bound by transport regulations. |
|
|
UN No. AIR |
Not bound by transport regulations. |
|
14.2 |
UN proper shipping name |
||
|
Not bound by transport regulations. |
||
14.3 |
Transport hazard class(es) |
||
|
Not bound by transport regulations. |
||
14.4 |
Packing group |
||
|
Not bound by transport regulations. |
||
14.5 |
Environmental hazards |
||
|
None. |
||
14.6 |
Special precautions for user |
||
|
No additional data available. |
||
14.7 |
Transport in bulk according to Annex II of MARPOL73/78 and the IBC code |
||
|
No additional data available. |
||
|
|
|
|
15.1 |
Safety, health and environmental regulations/legislation specific for the substance or mixture |
|
|
Statutory Instruments The Chemicals (Hazard Information and Packaging for Supply) Regulations 2009 (S.I 2009 No. 716). Guidance Notes Workplace Exposure Limits EH40. CHIP for everyone HSG(108). EU Legislation Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC, including amendments. |
|
15.2 |
Chemical safety assessment |
|
|
No additional information available. |
|
|
|
|
Hazard and/or Precautionary Statements in Full |
H315 Causes skin irritation. H317 May cause an allergic skin reaction.
H319 Causes serious eye irritation. |
Other Information |
None |
Revision Date |
12/07/2016 |
Reason for revision |
New SDS |
Rev No/Repl, SDS Generated |
01 |